Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to Michael R Narkewicz

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Narkewicz, Michael

One or more keywords matched the following properties of Narkewicz, Michael

Property

Value

keywords

Hepatitis C, Chronic

overview

My research is focused on 2 major areas: 1. Cystic Fibrosis Liver Disease. I focus on clinical / translational research focused on identifying the underlying mechanisms of liver disease in CF, developing tests to identify liver disease in CF and to predict the subsequent development of advanced liver disease in CF using radiology, biochemistry and clinical predictors. 2. Clinical trials of antiviral therapy for chronic hepatitis B and C in children and adolescents.

One or more keywords matched the following items that are connected to Narkewicz, Michael

Item Type	Name
Academic Article	Safety, efficacy and pharmacokinetics of peginterferon alpha2a (40 kd) in children with chronic hepatitis C.
Academic Article	The "C" of viral hepatitis in children.
Academic Article	NASPGHAN practice guidelines: Diagnosis and management of hepatitis C infection in infants, children, and adolescents.
Academic Article	Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis C.
Academic Article	Clearance of chronic hepatitis B virus infection in young children after alpha interferon treatment.
Academic Article	Neonatally acquired hepatitis C--not so risky?
Academic Article	Interferon treatment for chronic hepatitis B: enhanced response in children 5 years old or younger.
Academic Article	Modulation of the IL-12/IFN-gamma axis by IFN-alpha therapy for hepatitis C.
Academic Article	Recommendations for screening, monitoring, and referral of pediatric chronic hepatitis B.
Academic Article	Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.
Academic Article	Ophthalmologic complications in children with chronic hepatitis C treated with pegylated interferon.
Academic Article	The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C.
Academic Article	Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options.
Academic Article	Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trial.
Academic Article	Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirin.
Concept	Hepatitis B, Chronic
Academic Article	Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study.
Academic Article	CD4+ and CD8+ T Cell Activation in Children with Hepatitis C.
Academic Article	Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11.
Academic Article	Ledipasvir-Sofosbuvir for 12?Weeks in Children 3 to <6?Years Old With Chronic Hepatitis C.
Academic Article	Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Mini-Tabs Plus Ribavirin for Children Aged 3-11 Years with Hepatitis C Genotype 1a.
Academic Article	Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA Study.

Search Criteria

Hepatitis B Chronic